Introduction {#Sec1}
============

Chronic kidney disease (CKD) was an emerging public health problem worldwide and increased incident and prevalence of end-stage renal disease (ESRD) was noted in Taiwan^[@CR1]^. Impact of CKD elevated risk of all-cause mortality and cardiovascular diseases. Obesity was also a common risk factor for developing cardiovascular disease and metabolic syndrome in Taiwan^[@CR2],[@CR3]^. Previous studies had reported the relationship between obesity with renal function by using different anthropometric parameters. The risk of developing incident CKD was higher in the obese defined by body mass index (BMI) than normal weight subjects^[@CR4]^. In a previous study, waist-to-hip ratio (WHR) had more close association with the incident CKD and mortality rather than BMI^[@CR5]^. Madero *et al*. demonstrated that visceral adipose tissue had significant association with renal function decline and had risk of developing CKD^[@CR6]^.

Percent body fat (PBF) was suggested as a more valid predictor than BMI for the risk of cardiovascular diseases and other adverse outcomes^[@CR7]^. In a Korean study, increased PBF was significantly associated with inflammation and decline of renal function among elderly population. However, it appeared that little research findings were available concerning the effect of PBF variation on renal function in adult population. The objective of our study was to investigate whether PBF would contribute to the change of renal function in adult population from Taiwan.

Results {#Sec2}
=======

The demographic characteristics of study sample {#Sec3}
-----------------------------------------------

Characteristics of both male and female participants attended baseline examination and completed second visit were listed in Table [1](#Tab1){ref-type="table"}. The mean age of baseline visit and second visit in males and females were 38.85 ± 14.57, 39.79 ± 14.81 and 41.10 ± 16.03, 42.16 ± 16.15 years, respectively. The values of MDRDGFR were 100.62 ± 18.31, 100.36 ± 18.50 and 108.38 ± 22.40, 108.58 ± 22.97, respectively. The values of eGFR were 102.62 ± 15.22, 102.15 ± 15.46 and 120.84 ± 16.03, 120.30 ± 16.34, respectively. The prevalence of obesity was increased in second visit that 21.6% in males and 12.0% in females. Anthropometric parameters including BMI, PBF, and waist circumference (WC) and biochemical data had significant differences across these groups. There were significantly increased PBF, WC and decreased eGFR between baseline and second visit in both genders.Table 1Characteristics of study sample before and after follow-up.VariablesMaleFemaleBaseline Visit (N = 18514)Second Visit (N = 18514)P ValueBaseline Visit (N = 16573)Second Visit (N = 16573)P Value**Continuous Variables, mean (SD)**Age (years)38.85 (14.57)39.79 (14.81)\<0.00141.10 (16.03)42.16 (16.15)\<0.001BMI (kg/m^2^)24.76 (3.91)24.86 (3.93)\<0.00122.57 (3.96)22.68 (4.01)\<0.001PBF (%)24.85 (6.40)24.91 (6.40)\<0.00131.85 (6.72)31.93 (6.71)\<0.001WC (cm)84.21 (10.28)84.56 (10.28)\<0.00174.34 (10.27)74.72 (10.34)\<0.001MDRDGFR100.62 (18.31)100.36 (18.50)\<0.001108.38 (22.40)108.58 (22.97)\<0.001eGFR102.62 (15.22)102.15 (15.46)\<0.001120.84 (16.03)120.30 (16.34)\<0.001Cr0.81 (0.17)0.80 (0.17)\<0.0010.81 (0.17)0.80 (0.17)\<0.001UA (mg/dL)6.38 (1.31)6.38 (1.30)\<0.0014.71 (1.06)4.76 (1.07)\<0.001AST (U/L)22.42 (14.27)22.29 (14.53)\<0.00118.82 (10.37)18.91 (12.90)\<0.001Albumin (g/dL)4.59 (0.30)4.55 (0.29)\<0.0014.45 (0.30)4.41 (0.28)\<0.001TSH (uIU/mL)2.10 (1.43)2.11 (1.50)\<0.0012.41 (1.87)2.42 (1.88)\<0.001hsCRP (mg/dL)0.25 (0.56)0.25 (0.54)\<0.0010.21 (0.42)0.22 (0.44)\<0.001FPG (mg/dL)93.75 (22.96)94.32 (22.76)\<0.00191.08 (19.63)91.32 (19.75)\<0.001HDL-C (mg/dL)48.50 (11.64)48.22 (11.44)\<0.00160.36 (14.16)59.78 (13.77)\<0.001**Category Variables, (%)**Proteinuria5244 (28.3)4518 (27.3)\<0.0014225 (25.5)5043 (27.2)\<0.001Smoking2989 (16.1)559 (3.4)0.0023138 (16.9)526 (3.2)0.450HTN2676 (14.5)1340 (8.1)\<0.0013128 (16.9)1754 (10.6)\<0.001DM505 (3.0)750 (4.1)\<0.001806 (4.4)511 (3.1)\<0.001Obese3706 (20.0)4008 (21.6)\<0.0011731 (10.4)1985 (12.0)\<0.001BMI, body mass index; PBF, percentage body fat; WC, waist circumference; MDRDGFR, Modification of Diet in Renal Disease Glomerular Filtration Rate; eGFR, estimated Glomerular Filtration Rate; Cr, creatinine; UA, uric acid; AST, aspartate transaminase; TSH, thyroid stimulating hormone; hsCRP, high sensitive C-reactive protein; FPG, fasting plasma glucose; HDL-C, high density lipoprotein cholesterol; HTN, hypertension; DM, diabetes mellitus.

Association among changes of PBF, WC and changes of renal function during follow-up {#Sec4}
-----------------------------------------------------------------------------------

In Table [2](#Tab2){ref-type="table"}, the changes of PBF and WC had significant associations with the changes of estimated glomerular filtration rate (eGFR) during the follow-up period. After multivariable adjustment, increased PBF had more closely associated with reduced renal function than WC with β values of −0.174, −0.172 and −0.173 (95% confidence interval (CI) = −0.234, −0.114; −0.233, −0.112; −0.233, −0.112) in each model, respectively.Table 2Association among changes of PBF, WC, and changes of renal function in the period of follow-up.VariablesModel^a^ 1\
*β*^b^ (95% CI)P ValueModel^a^ 2\
*β*^b^ (95% CI)P ValueModel^a^ 3\
*β*^b^ (95% CI)P Value**Changes of eGFR**Changes of PBF−0.174 (−0.234, −0.114)\<0.001−0.172 (−0.233, −0.112)\<0.001−0.173 (−0.233, −0.112)\<0.001Changes of WC−0.078 (−0.105, −0.050)\<0.001−0.077 (−0.105, −0.050)\<0.001−0.077 (−0.104, −0.049)\<0.001^a^Adjusted covariates:Model 1 = age + gender + BMI.Model 2 = Model 1 + proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, HDL-C.Model 3 = Model 2 + history of smoking, HTN, DM.

Gender differences in the association among changes of PBF, WC and changes of renal function were also presented in Table [3](#Tab3){ref-type="table"}. Both PBF and WC had negative relationship with the changes of eGFR, especially in male population. The increased β values of PBF was higher than those of WC in each adjusted model.Table 3Association among changes of PBF, WC, and changes of renal function categorized by gender.GenderVariablesModel^a^ 1\
*β*^b^ (95% CI)P ValueModel^a^ 2\
*β*^b^ (95% CI)P ValueModel^a^ 3\
*β*^b^ (95% CI)P Value**Changes of eGFR**MaleChanges of PBF−0.280 (−0.375, −0.186)\<0.001−0.277 (−0.372, −0.182)\<0.001−0.276 (−0.371, −0.181)\<0.001Changes of WC−0.161 (−0.208, −0.113)\<0.001−0.162 (−0.209, −0.114)\<0.001−0.159 (−0.207, −0.112)\<0.001FemaleChanges of PBF−0.022 (−0.085, 0.042)0.503−0.022 (−0.086, 0.042)0.500−0.021 (−0.085, 0.043)0.524Changes of WC−0.002 (−0.028, 0.025)0.889−0.001 (−0.028, 0.025)0.926−0.001 (−0.028, 0.025)0.931^a^Adjusted covariates:Model 1 = age + BMI.Model 2 = Model 1 + proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, HDL-C.Model 3 = Model 2 + history of smoking, HTN, DM.

Hazard ratios for predicting the changes of renal function stratified by gender {#Sec5}
-------------------------------------------------------------------------------

Adjusted hazard ratios (HRs) of the changes of PBF and WC for predicting the changes of renal function in males and females were presented in Table [4](#Tab4){ref-type="table"}. However, no significant difference was noted among the adjusted models in the changes of PBF or WC among both genders.Table 4Cox hazard proportional model for changes of PBF and WC in predicting changes of renal function.VariablesModel^a^ 1 HR (95% CI)P ValueModel^a^ 2 HR (95% CI)P ValueModel^a^ 3 HR (95% CI)P Value**Changes of eGFRChanges of PBF**Total0.968 (0.851--1.101)0.6220.979 (0.862--1.111)0.7410.980 (0.863--1.113)0.753Male1.051 (0.876--1.261)0.5941.059 (0.888--1.264)0.5231.061 (0.882--1.275)0.531Female0.898 (0.733--1.100)0.2990.890 (0.726--1.090)0.2610.894 (0.731--1.093)0.274**Changes of WC**Total0.985 (0.927--1.046)0.6190.988 (0.928--1.051)0.6950.988 (0.928--1.051)0.695Male0.984 (0.890--1.088)0.7580.999 (0.900--1.109)0.9871.001 (0.899--1.114)0.990Female0.993 (0.914--1.078)0.8580.995 (0.916--1.081)0.9130.994 (0.915--1.079)0.880^a^Adjusted covariates:Model 1 = age + gender + BMI.Model 2 = Model 1 + proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, HDL-C.Model 3 = Model 2 + history of smoking, HTN, DM.

Adjusted odds ratios for developing CKD stratified by gender {#Sec6}
------------------------------------------------------------

Because the Cox proportional hazard models did not show any significant effect of the changes of PBF and WC on renal function, we further determined gender specific cut-off values of baseline PBF for CKD. Optimal cut-off values of baseline PBF categorized by gender were assessed by using receiver--operator characteristic (ROC) curve analysis in our study (Table [5](#Tab5){ref-type="table"}). In male population, the area under the ROC (AUROC) value was 0.531 (95% CI: 0.425--0.637) and the optimal cut-off value was 21.55 with sensitivity and specificity of 85% and 30%. In females, the AUROC value was 0.613 (95% CI: 0.547--0.680) and the optimal cut-off value was 40.75 with sensitivity and specificity of 30% and 91%.Table 5Optimal cut-off values of PBF in males and females.AUC (95%CI)SensitivitySpecificityP-valueCut-off valuesMale0.531 (0.425--0.637)85%30%\<0.00121.55Female0.613 (0.547--0.680)30%91%\<0.00140.75

Association between the optimal cut-off values of baseline PBF with the presence of the future CKD was shown in Table [6](#Tab6){ref-type="table"}. Female participants with increased PBF that over cut-off values had increased risks for predicting the presence of future CKD with ORs of 2.679, 2.360 and 2.298 (95%CI = 1.203--5.964; 1.039--5.363; 1.006--5.252) in each adjusted model, respectively. There was no interaction between cut-off values of baseline PBF and the future CKD. The interaction term between these factors was not significant in all models (*P* \> 0.05).Table 6Adjusted odd ratio for CKD stratified by gender specific cut-off values of PBF.GenderCut-off values of PBFModel^a^ 1\
OR (95% CI)*P* ValueModel^a^ 2\
OR (95% CI)*P* ValueModel^a^ 3\
OR (95% CI)*P* ValueCKDMale21.550.782 (0.178--3.443)0.7450.662 (0.148--2.953)0.5890.656 (0.147--2.933)0.581Female40.752.679 (1.203--5.964)0.0162.360 (1.039--5.363)0.0402.298 (1.006--5.252)0.048^a^Adjusted covariates:Model 1 = age + gender + BMI.Model 2 = Model 1 + proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, HDL-C.Model 3 = Model 2 + history of smoking, HTN, DM.

Discussion {#Sec7}
==========

In our study, we highlighted the detrimental impact of body fat accumulation in the decline of renal function in general population derived from the longitudinal analysis of health examinations. Particularly, female participants with higher baseline PBF over cut-off values had higher risks of developing future CKD. To the best of our knowledge, the present study was the first to explore the relationship between PBF and renal function, defined by Taiwanese MDRD equation, and predict the risk of future CKD by baseline PBF in a large population-based survey which was composed of general population in Taiwan.

The interactions between obesity and renal function had been reported in previous studies. In a cross-sectional observational study, subjects with increased BMI was suggested to have increased risk of CKD^[@CR8]^. Boer *et al*. demonstrated that obesity was associated with a decline in GFR in a community-based population of older adults^[@CR9]^. Central body fat distribution was significantly associated with impaired renal function^[@CR10]^. Increased abdominal obesity, defined by WC and WHR, was positively related to renal function impairment in Chinese population^[@CR11]^. In a prospective study composed of 390 elderly participants, Oh *et al*. proposed that a change in PBF was associated with a decline in eGFR estimated by CKD-EPI equation that the highest tertile of change in PBF had increased risk for rapid progression of renal dysfunction^[@CR12]^. It was similar with our findings that changes of PBF had adverse effect on renal function. However, the estimation of GFR in the present study was used by Taiwanese MDRD equation, which was more suitable for Taiwanese adults than other measurements^[@CR13]^. In addition, the study sample was obtained from a large-scale general population. PBF also had predictive ability for the future CKD in female population by a longitudinal analysis.

The exact mechanisms of obesity on renal function decline was unclear. Numerous studies had reported that deteriorated renal consequences by adipose tissue might include inflammation, insulin resistance and renin-angiotensin-aldosterone system (RAAS). Various cytokines such as interleukin-6 (IL-6), IL-8, IL-10 and tumor necrosis factor-alpha (TNF-alpha) were released by adipose tissue in obese subjects^[@CR14]^. Increased production and decreased clearance of pro-inflammatory cytokines was proposed to cause chronic inflammatory status in CKD^[@CR15]^. Emerging evidence had considered adipose tissue as an important endocrine organ which produced adiponectin, leptin, and resistin^[@CR16]--[@CR18]^. These hormones could lead to insulin resistance and activate progression of renal disease by worsening renal hemodynamics by several pathways including sympathetic nervous system excitation, sodium retention and downregulation of the natriuretic peptide system^[@CR19]^. The RAAS was well known for regulating blood pressure and determining target-organ damage^[@CR20]^. Angiotensin II was the key factor of the RAAS to increase the glomerular hydraulic pressure and the ultrafiltration of plasma proteins predominantly by vasoconstrictor effect of post glomerular arterioles, leading to the onset and progression of chronic renal damage^[@CR21]^. Adipose tissue was regarded as the source of angiotensin that a local RAAS was present in human adipose tissue^[@CR22]^. Besides, increased angiotensinogen produced by adipose tissue might be responsible in part for the metabolic and inflammatory disorders that associated with chronic renal diseases^[@CR23]^.

General female subjects with increased baseline PBF over the optimal cut-off values had increased likelihood for predicting the future CKD in our study. Sex difference in adipose tissue might be multifactorial. Females experienced a continuous increase in PBF throughout development and they had higher PBF than males during puberty^[@CR24]^. Leptin was primarily produced by adipose tissue with circulating levels being positively correlated with total body fat^[@CR25]^. Hellstrom *et al*. reported the gender difference in circulating leptin concentrations that females had higher levels than males^[@CR26]^. Renal function decline was caused by increased leptin via triggering a paracrine interaction in proliferation of glomerular endothelial cells, exerting sympathetic nervous activity, and inducing reactive oxygen species^[@CR17]^.

The strengths of our study are a large population-based survey, appropriate renal function measurement for the study sample, and a cohort analysis for the association between PBF and risks of the future CKD. However, there are several potential limitations among our study. First, the dataset was derived from only an Asian population. Therefore, the limited ethnicity diversity in the participants might not reflect the interaction in terms of racial differences. Second, the measurement of body composition among the study was used by BIA but not by DEXA, the standard method for measuring body fat and muscle mass in general. Next, the biological mechanism through which PBF acted on renal function were not well elucidated. Further researches into the potential underpinnings of the relationship were needed. Last, the information about menopause and postmenopausal years of female participants was unavailable in our study. Sex hormones strongly influence body fat distribution and adipocyte differentiation^[@CR27]^. Previous studies have reported that menopause-related changes in body fat distribution had risk of cardiometabolic diseases during postmenopausal years^[@CR28]^. Decrease in estrogen secretion is considered to have a significant effect of obesity in menopausal females^[@CR29]^.

Conclusion {#Sec8}
==========

Our findings demonstrated the association between the changes of PBF and the decline of renal function in adult population in Taiwan. PBF might be used to predict the risk of the future CKD, particularly in females. Measurement of body fat might provide as a useful tool for surveillance of renal function decline in adult population.

Methods {#Sec9}
=======

Study design {#Sec10}
------------

The present study was performed in the health examinations of Tri-Service General Hospital (TSGH) from 2010 to 2016. Study approval was conduct by the Institutional Review Board (IRB) of TSGH. The TSGH IRB waived the need to obtain individual informed consent because these data were analyzed anonymously. All methods were performed in accordance with the relevant guidelines and regulations of TSGH IRB. The flow chart of the study was shown in Fig. [1](#Fig1){ref-type="fig"}. participants who finished biochemical examination, body composition measurement, and renal function measurement at baseline and second visit were included (male: 18514/female: 16573).Figure 1Flow chart which represented the steps of analysis performed in the study.

Measurement of renal function {#Sec11}
-----------------------------

Previous studies had indicated that eGFR using the Modification of Diet in Renal Disease (MDRD) or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations might not be accurate for Asians^[@CR30],[@CR31]^. Thus, specialists in Japan, China and Thailand subsequently presented different estimations suitable for their citizens^[@CR32]--[@CR34]^. In our study, eGFR was estimated by Taiwanese MDRD equation, reported by Chen *et al*., which was better than other renal function equations for Taiwanese adults^[@CR13]^. The formula of Taiwanese MDRD equation was 1.3096 X MDRD^0.912^. Serum creatinine (Cr) was measured by the uncompensated Jaffe method with the alkaline picrate kinetic test.

Diagnosis of chronic kidney disease {#Sec12}
-----------------------------------

According to the definition of the Kidney Disease Outcomes Quality Initiative (KDOQI), individuals with a GFR \<60 ml/min/1.73 m^2^ for 3 months were identified as having CKD, irrespective of the presence or absence of kidney damage^[@CR35]^. Markers of kidney damage included: hematuria, electrolyte abnormalities, structural abnormalities detected by imaging^[@CR36]^.

Measurement of body composition {#Sec13}
-------------------------------

BMI was generally used as an attempt to quantify the amount of tissue mass in an individual and a standard for recording obesity^[@CR37]^. BMI was estimated based on a general formula that the weight of the in kilograms divided by the square of the height in meters (kg/m^2^) of a participant (kg/m^2^). WC was measured at mid-level between the iliac crest and the lower border of the 12^th^ rib. Bioelectrical impedance analysis (BIA) was an effective and valid method for assessing body composition^[@CR38]^. It was an alternative to more invasive and expensive methods like dual-energy X-ray absorptiometry, computerized tomography, and magnetic resonance imaging. In the present study, we detected PBF by using BIA (InBody720, Biospace, Inc., Cerritos, CA, USA).

Covariates measurement {#Sec14}
----------------------

Biochemical data were collected by drawing blood samples from subjects after fasting for at least 8 hours. Fasting plasma glucose (FPG) was detected using a glucose oxidase method. Aspartate transaminase (AST) was measured by an enzymatic colorimetric method. The latex-enhanced nephelometry was used to detect high sensitivity C-reactive protein (hsCRP). Uric acid (UA) was measured by the Hitachi 737 automated multichannel chemistry analyzer (Boehringer Mannheim Diagnostics, Indianapolis, IN, USA). Thyroid stimulating hormone (TSH) was accessed by an immune-enzymatic assay. High density lipoprotein cholesterol (HDL-C) were analyzed by using an enzymatic colorimetric method. All experimental methods were performed in accordance with the relevant guidelines and regulations of TSGH.

Statistical analysis {#Sec15}
--------------------

Statistical estimations used in the study were performed by the Statistical Package for the Social Sciences, version18.0 (SPSS Inc., Chicago, IL, USA) for Windows. The differences between males and females in terms of demographic information and biochemistry data were examined by Student's t test and Pearson's chi-square test. A two-sided *p*-value of ≤0.05 was regarded as the threshold for statistical significance. A ROC curve was used to calculate the scores of baseline PBF to predict the presence of CKD, including gender specific cut-off values, AUROC and the corresponding 95%CI. Extend-model approach was performed in the study with multivariable adjustment for pertinent clinical variables as follows: Model 1 included age, gender, and BMI; Model 2 included Model 1 plus proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, and HDL-C; Model 3 included Model 2 plus history of smoking, hypertension (HTN), and diabetes mellitus (DM). A multivariable linear regression model was performed for the association between the changes of PBF and WC with the changes of renal function. A proportional Cox hazard regression model was conducted for the changes of PBF and WC to predict the incident changes of eGFR during the follow-up. A multivariable logistic regression was used for the associations between cut-off values of baseline PBF and the future CKD.
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